Centocor Inc said entered agreement & lt ; Ajinomoto Co Inc > exclusive distribution Centocor 's Panorex Japan .
Panorex monoclonal antibody , made recombinant gene technology , treatment pancreatic cancer .
It tested human Europe U.S. since 1982 .
Centocor said intends begin clinical trial U.S. year modified form drug .
Under agreement , Ajinomoto conduct clinical test drug Japan company jointly file marketing approval product Japan .
Reuter & # 3 ; 